Each material 8-K filed by a company listed on a US stock exchange (NYSE, Nasdaq, Cboe), read and summarized: what happened, the key numbers, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). This page lists the last 45 days; every brief stays on its company's 8-K page (4787 companies, A–Z).
NRG Energy agreed to sell six natural-gas generation assets, totaling 4.9 GW, to an affiliate of LS Power for $4 billion in cash, subject to customary adjustments. The sale is targeted to close in the second quarter of 2027, pending regulatory approvals. NRG plans to use the proceeds for $3 billion of share repurchases across 2026 and 2027 and $2 billion of debt reduction at closing.
Purchase price of $4 billion in cash, subject to working capital and other closing adjustments; implied 2027 valuation of 8.0x EV/Adj. EBITDA
Six assets totaling 4.9 GW: Ravenswood (NYISO), Ocean State Power and Wallingford (ISO-NE), and Jack County, Johnson County and R.W. Miller (ERCOT)
Targeted closing in the second quarter of 2027, subject to HSR, FERC and New York State Public Service Commission approvals
Planned 2027 capital allocation includes $3 billion of share repurchases across 2026 and 2027, with an incremental $1 billion starting before the end of Q4 2026
DTE Energy said it is selling primarily all of its DTE Vantage business for approximately $3 billion to institutional investors advised by J.P. Morgan Asset Management, with closing targeted in the first half of 2027. The company also raised its long-term operating EPS growth target to greater than 9% through 2031, up from a prior 6% to 8% range, and increased its five-year utility capital plan to $44 billion, which it says is nearly 30% above the prior plan.
Transaction value of approximately $3 billion for primarily all DTE Vantage assets, excluding EES Coke and several named custom energy solutions and renewable energy sites
Target closing in the first half of 2027; sale proceeds will be invested in utility businesses, reducing equity and debt needs
Operating EPS growth target of greater than 9% from 2027 to 2031, versus prior 6% to 8% growth profile; 2026 operating EPS guidance of $7.59 to $7.73 remains, with the company positioned to achieve the high end
Average annual equity issuances targeted at about $1 billion from 2027 to 2031; dividend to increase 7% in 2027
Vistra Corp. has completed its acquisition of Q-Generation Holdings, LLC, adding 10 natural gas generation facilities representing approximately 5,500 megawatts of capacity. The transaction consideration included approximately $2.2 billion in cash and 5,000,000 shares of Vistra common stock, alongside the assumption and planned repayment of approximately $1.7 billion of acquired indebtedness.
Completed the acquisition of Q-Generation Holdings, LLC on October 30, 2026, adding approximately 5,500 megawatts of natural gas capacity across 10 facilities.
Consideration included approximately $2.2 billion in cash (net of adjustments) and 5,000,000 shares of Vistra common stock valued at $185 per share.
Assumed approximately $1.7 billion of indebtedness, which Vistra expects to repay in full on or about November 5, 2026.
Luxfer Holdings shareholders approved the proposed acquisition by affiliates of Wynnchurch Capital at meetings held on November 4, 2026, in London. Holders will receive $17.37 per share in cash upon completion, and the shares will stop trading on the New York Stock Exchange once the deal closes.
Scheme Meeting: 17,447,419 votes for and 1,556,495 against the Scheme of Arrangement, approved by the required 75% threshold
Company GM: 17,928,650 votes for and 1,557,569 against the scheme implementation and articles amendment proposal
Court sanction hearing scheduled for November 17, 2026; scheme expected to take effect on or around November 18, 2026
Transaction expected to close by the end of November 2026, after which Luxfer becomes privately held
Lumentum Holdings Inc. entered into a definitive merger agreement on November 1, 2026, under which Marvell Technology, Inc. will acquire Lumentum in an all-stock transaction with an implied enterprise value of $115 billion. Lumentum stockholders will receive 4.500 shares of Marvell common stock for each share of Lumentum common stock they own. The transaction is expected to close in the first half of calendar year 2028, subject to regulatory and stockholder approvals.
On November 1, 2026, Lumentum entered into an agreement to be acquired by Marvell Technology in an all-stock transaction.
Lumentum stockholders will receive a fixed exchange ratio of 4.500 shares of Marvell common stock for each share of Lumentum common stock, representing an implied enterprise value of $115 billion.
The transaction is expected to close in the first half of calendar year 2028.
Following closing, current Marvell stockholders will own approximately 67% and Lumentum stockholders will own approximately 33% of the combined company.
Marvell Technology has entered into a definitive agreement to acquire Lumentum Holdings in an all-stock transaction with an implied enterprise value of $115 billion for Lumentum. Lumentum stockholders will receive 4.500 shares of Marvell common stock for each share owned, and the deal is expected to close in the first half of calendar year 2028. Additionally, Marvell reported preliminary revenue for the third quarter of fiscal 2027.
Lumentum stockholders will receive a fixed exchange ratio of 4.500 Marvell shares per Lumentum share.
The transaction carries an implied enterprise value of $115 billion for Lumentum, representing about $1,132 per share.
Post-closing, Marvell stockholders will own approximately 67% and Lumentum stockholders approximately 33% of the combined company.
The deal is expected to close in the first half of calendar year 2028, pending approvals.
Lazard, Inc. has completed its acquisition of Campbell Lutyens and launched Lazard CL, a combined private capital advisory business. The transaction expands Lazard's private capital advisory and secondary fundraising capabilities, with management anticipating approximately $500 million in combined revenue in 2027.
The acquisition closed on November 2, 2026, establishing Lazard CL as a combined private capital advisory business.
Lazard CL anticipates generating approximately $500 million in combined revenue in 2027.
The business brings together more than 300 advisory professionals across 19 offices globally.
The companies have collectively advised on more than $1 trillion of primary capital raised and secondary transaction volume over the past four decades.
ADT Inc. agreed to be acquired by Thrive Holdings in an all-cash deal valued at approximately $7.6 billion in equity and $15.3 billion in enterprise value. The $10.00 per share price is a 45.6% premium to the unaffected closing price of $6.87 on October 27, 2026, and ADT will become privately held with its stock ceasing to trade on the New York Stock Exchange upon completion.
Stockholders will receive $10.00 per share in cash, a 45.6% premium to the $6.87 unaffected close on October 27, 2026.
The deal values ADT at about $7.6 billion in equity value and $15.3 billion in enterprise value.
Financing commitments come solely from funds managed by affiliates of Apollo Global Management, and the deal is not subject to a financing condition.
The transaction is expected to close in the first quarter of 2027, subject to stockholder and U.S. antitrust approval; a go-shop period runs until 11:59 p.m. New York time on November 28, 2026.
DoorDash reported third-quarter 2026 financial results with marketplace GOV of $33.9 billion and GAAP net income of $466 million. Additionally, the company announced a definitive agreement to acquire Instacart for $65.00 per share, representing an equity value of approximately $17 billion. DoorDash also issued financial guidance for the fourth quarter of 2026.
Total orders increased 28% year-over-year to 993 million in Q3 2026.
GAAP net income attributable to common stockholders reached $466 million in Q3 2026.
DoorDash agreed to acquire Instacart for $65.00 per share in a transaction valued at approximately $17 billion.
Q4 2026 marketplace GOV is projected to be between $35.4 billion and $36.4 billion.
Ultralife agreed on October 27, 2026 to be acquired by EnerSys through a two-step tender offer and merger, at $16.00 per share in cash, with a total enterprise value of approximately $320 million. The deal is expected to close in the first quarter of calendar 2027 and, if completed, would remove Ultralife's common stock from public markets.
Offer price is $16.00 per share in cash, a stated premium of 166% to the October 26, 2026 closing price
Total enterprise value is approximately $320 million; EnerSys plans to fund it with cash on hand and has no financing contingency
Termination fees of $10,300,000 apply in specified circumstances to either party; closing expected in Q1 2027, with an Outside Date of April 27, 2027
A. O. Smith agreed to sell an 81% equity interest in its China business to CPE, an alternative asset manager, subject to closing conditions and regulatory approvals. The company keeps a 19% stake and a long-term brand license, and expects the deal to close in the first half of 2027. The company says it intends to use after-tax proceeds and repatriated cash mainly for share repurchases.
China business valued at about $400 million on a cash-free, debt-free basis; total value including licensing economics expected to exceed $500 million
About $80 million of cash currently held in China would be repatriated
A. O. Smith retains a 19% interest and receives royalties under a long-term brand license
Expected close in the first half of 2027; third quarter results and guidance due October 29, 2026
On October 27, 2026, CoStar Group signed a merger agreement through its subsidiaries to acquire Vexcel Group, a provider of aerial imagery and geospatial data, for $730 million in cash, subject to customary adjustments. Closing depends on antitrust waiting periods and other conditions, and the deal does not require CoStar stockholder approval or financing. The same day, CoStar reported third-quarter 2026 revenue of $952 million, up 14%, net income of $74 million versus a $31 million loss a year earlier, and raised its full-year 2026 Adjusted EBITDA guidance to $820 million to $840 million.
Vexcel purchase price is $730 million in cash; the agreement can be terminated if the deal is not completed by July 27, 2027.
Q3 2026 revenue was $952 million, up from $834 million; net income was $74 million and diluted EPS was $0.18.
Q3 Adjusted EBITDA was $229 million versus $114 million a year earlier; 2026 Adjusted EBITDA guidance raised to $820 million to $840 million and revenue guidance to $3.75 billion to $3.77 billion.
Vertiv Holdings Co. completed its acquisition of Utility Innovation Holdings, Inc. for approximately $1.45 billion in upfront cash, with up to $1.15 billion in additional contingent cash consideration based on EBITDA targets. The transaction expands Vertiv's portfolio into microgrids and behind-the-meter power architecture to help data center operators address power constraints.
Vertiv completed the acquisition on October 27, 2026, paying approximately $1.45 billion in upfront cash.
Additional contingent cash consideration of up to $1.15 billion may be paid in two tranches based on EBITDA targets.
The acquisition purchase price represents approximately 13x expected UIG 2027 EBITDA.
On October 26, 2026, Francisco Partners completed its acquisition of Weave Communications, and Weave stock stopped trading on the New York Stock Exchange. Stockholders received $7.40 in cash per share, and the company repaid its existing credit facility and entered a new credit agreement with Hercules Capital. Shareholders no longer hold Weave stock, and the company will operate as a privately held company.
Stockholders receive $7.40 per share in cash, a premium of about 34% to the unaffected closing price on August 17, 2026.
Total merger consideration was about $597.46 million; the transaction was valued at about $650 million.
Weave common stock ceased trading and is no longer listed on the NYSE.
New Credit Agreement with Hercules Capital provides a $190 million initial term loan, a $25 million delayed draw term loan and a $25 million revolving credit facility.
Surgery Partners agreed on October 23, 2026 to be acquired by Spyglass Topco, LLC, an entity tied to HealthSpan Partners, in a deal the company values at about $5.7 billion enterprise value. Public shareholders other than Bain Capital affiliates would receive $23.50 in cash per share, and the company would become privately held and delist from Nasdaq if the deal closes. Completion depends on stockholder approval, regulatory clearance, and other customary conditions, with closing expected in the first quarter of 2027.
Per-share cash consideration of $23.50 for common stock, excluding Bain Capital rollover shares, appraisal shares and certain other holdings
Bain Capital affiliates, owning about 39% of outstanding shares, agreed to vote in favor and roll over their equity into the acquiring entity
Expected closing in the first quarter of 2027; either party may terminate if the merger is not completed by July 23, 2027, subject to extensions
Stockholder approval requires a majority of outstanding shares and a majority of votes cast by disinterested stockholders
MarketAxess said the US Department of Justice and Federal Trade Commission granted early termination of the Hart-Scott-Rodino waiting period, effective October 21, 2026. This satisfies the HSR Act condition to close the merger with Intercontinental Exchange, which was announced July 29, 2026. The merger still requires approval by MarketAxess stockholders and other required regulatory approvals.
DOJ and FTC granted early termination of the HSR Act waiting period, effective October 21, 2026
The HSR Act closing condition is now satisfied
Remaining conditions include stockholder approval and other required regulatory approvals
Definitive Proxy Statement was filed with the SEC on September 18, 2026
Silence Therapeutics agreed on October 18, 2026 to be acquired by Merck KGaA, Darmstadt, Germany in an all-cash deal valued at about $1.3 billion in equity value. Shareholders and ADS holders would receive $20.00 in cash per American Depositary Share, a 130% premium to the October 16, 2026 closing ADS price, and the transaction was unanimously approved by the Silence board.
Consideration of $20.00 in cash per ADS, with each ADS representing three ordinary shares ($6.6667 per share)
Equity value of approximately $1.3 billion and enterprise value of $1.1 billion; 82% premium to the 30-day volume-weighted average price of $10.99
Expected close in the first quarter of 2027, subject to shareholder approval, High Court sanction and regulatory approvals; End Date of April 30, 2027
Silence must pay Merck KGaA a $13 million termination fee in certain circumstances; securityholders with about 14% of voting power signed voting and support agreements
Silgan Holdings said it will combine its Metal Containers and Food and Beverage Flat Cap Closures businesses with Trivium Packaging in a partnership with funds affiliated with American Industrial Partners (AIP), with the partnership acquiring Trivium in an all-cash deal at a $3.4 billion enterprise value. Silgan expects about $2.3 billion of cash proceeds and a 60% stake in the new partnership, and it expects the deal to be at least 15% accretive to adjusted EPS and free cash flow, including $225 million of expected synergies. The deal is expected to close in mid-2027, subject to regulatory approvals and other conditions, and Silgan confirmed its third-quarter and full-year 2026 adjusted EPS outlook.
Silgan MCC will combine Silgan's Metal Containers and Flat Cap Closures businesses with Trivium at a $3.4 billion enterprise value for Trivium, or 7.1x LTM Adjusted EBITDA
Silgan receives approximately $2.3 billion of cash proceeds and retains 60% ownership; AIP holds 40% and contributes approximately $1.0 billion of cash equity
Expected synergies of $225 million by year three, with about $75 million in year one and $150 million in year two; Silgan expects at least 15% adjusted EPS accretion
Expected close in mid-2027; Silgan MCC net leverage estimated at about 4.0x pro forma
International Seaways agreed to acquire Bruton Limited, a Bermuda tanker company valued at about $370 million, through a share exchange with holders of about 50.5% of Bruton's shares and a later merger. The same release gave preliminary third-quarter 2026 results, with shipping revenues of $480-$490 million and net income of $340-$350 million, including a gain of about $50 million on a vessel sale, while blended spot earnings fell from the second quarter but rose from a year earlier. Shareholders should note that the Bruton merger is subject to a Bruton shareholder vote and that the share issuance will dilute existing holders.
Bruton is valued at about $370 million; holders of about 50.5% of its shares will exchange them for 0.05190 Seaways shares each, with that exchange expected to close on or about October 20, 2026.
Bruton holders of 10,000 or fewer shares will receive $6.3044 cash per share; the merger is expected to close after Bruton's special meeting on or about October 30, 2026, and either party may terminate if it has not closed by November 15, 2
Preliminary Q3 2026: shipping revenues of about $480-$490 million, net income of about $340-$350 million including a gain of about $50 million on a 2012-built Suezmax sale, and total liquidity of about $965 million.
Seaways expects to issue about 3.12 million shares, about 96% of the total consideration; blended spot earnings were about $68,000 per day in Q3 versus $79,000 in Q2 2026 and $29,000 in Q3 2025.
Varonis Systems agreed to be acquired by Proofpoint, a Thoma Bravo portfolio company, in an all-cash transaction valued at about $6.3 billion. Varonis shareholders would receive $49.75 per share, a 52% premium to the June 22, 2026 closing price of $32.71, and the deal requires shareholder and regulatory approval, with closing expected in the first half of 2027. Varonis shares would stop trading on Nasdaq and the company would become private.
Merger consideration of $49.75 per share in cash, a 52% premium to the $32.71 close on June 22, 2026 and 17% above the $42.35 close on September 1, 2026
Transaction valued at about $6.3 billion, or about 53x LTM free cash flow and 8.4x LTM revenue
Varonis must pay Proofpoint a $211.7 million termination fee in specified circumstances; Proofpoint would pay a $423.3 million reverse termination fee in specified circumstances
Expected to close in the first half of 2027; either party may terminate if the merger is not completed by July 15, 2027, subject to a three-month regulatory extension
Bumble Inc. agreed on October 12, 2026 to be acquired by Ithaca Holdings in an all-cash deal valuing the company at $1.3 billion, with Class A shareholders receiving $6.05 per share, a premium of about 138% to the unaffected October 9, 2026 closing price. Stockholder written consent has already been delivered by the Principal Stockholders, so no further shareholder vote is required, and the company will not issue a third-quarter 2026 earnings release.
Class A common stock holders to receive $6.05 per share in cash, about 138% premium to the unaffected closing price on October 9, 2026
Company termination fee of $29 million may apply under certain circumstances; Ithaca Holdings would pay a $102 million parent termination fee in specified cases, to be deposited in escrow by October 19, 2026
Merger must close by July 12, 2027 or either party may terminate; the company will file its Form 10-Q for the third quarter by November 9, 2026 and will not hold an earnings call
Gran Tierra stockholders approved the sale of the company's Colombian and Ecuadorian businesses to Maurel & Prom at a special meeting on October 9, 2026. The company expects about $315 million in net cash proceeds and targets closing on or about December 31, 2026, pending regulatory approvals in Colombia and Ecuador. Stockholders did not approve the non-binding advisory vote on compensation for named executive officers tied to the sale, with more votes against than for.
Sale approved: 19,351,115 shares for, 32,492 against, 7,328 abstaining, out of 19,390,935 shares represented at the meeting
Advisory vote on sale-related executive compensation: 9,557,007 for, 9,658,068 against, 175,860 abstaining
Expected net cash proceeds of about $315 million: about $250 million at closing and about $65 million 364 days later
Closing targeted on or about December 31, 2026, subject to regulatory approvals in Colombia and Ecuador; any share repurchase depends on completion of the sale
Pacira BioSciences agreed to be acquired by Viatris through a cash tender offer at $36.50 per share, followed by a second-step merger, for an aggregate equity value of $1.65 billion. Pacira's board unanimously recommends that shareholders tender their shares, and the deal is expected to close by the end of 2026, subject to a majority tender and regulatory clearance.
Cash offer of $36.50 per share, with a $1.65 billion aggregate equity value
Tender offer to start within 15 business days of the October 8, 2026 agreement; deal expected to close by end of 2026
Pacira would pay Viatris a $62.0 million termination fee if it accepts a superior offer
Pacira generated approximately $746 million in revenue and $177 million in adjusted EBITDA in the twelve months ended June 30, 2026
Option Care Health entered into a merger agreement on October 5, 2026, under which an investor group of CD&R affiliates and McKesson Corporation would acquire the company for $32.05 per share in cash, a total enterprise value of approximately $5.8 billion. The price represents a premium of approximately 37% to the October 5, 2026 closing share price, and the company's board unanimously recommended the deal to stockholders. Shareholders would receive cash and the stock would no longer be publicly listed on Nasdaq once the deal closes, which is expected in the first half of 2027, subject to stockholder and regulatory approvals.
Cash consideration of $32.05 per share, a premium of approximately 37% to the October 5, 2026 closing price
Total enterprise value of approximately $5.8 billion; McKesson to invest approximately $1.4 billion for an approximately 49% minority interest
Closing expected in the first half of calendar year 2027, subject to stockholder approval and regulatory approvals
Company is withdrawing its previously disclosed 2026 guidance and will not host a call for its third quarter 2026 results, which it expects to release on November 4, 2026
Axe Compute completed its acquisition of 100% of the entity that owns the 288-server Georgia AI cluster from Duos Technologies on September 30, 2026. The company paid off the entity's roughly $87.8 million asset-backed loan with no new equity issued, and owes Duos a remaining $42.9 million deferred purchase price. The customer agreement was extended from three to five years, and the company expects about $364.6 million in revenue over its life.
Acquisition closed September 30, 2026; the $87.8 million asset-backed loan was repaid in full with no new equity issued.
Remaining $42.9 million deferred purchase price is payable to Duos at $715,000 per month, due by the earlier of 12 months after signing or a financing secured by the cluster.
Customer agreement extended from three years to five years, running through 2031 with renewal options.
Duos covers colocation and energy costs for the five-year term; the company expects about $364.6 million in revenue over the agreement's life.
Matador Resources completed its acquisition of Paloma Permian LLC on October 1, 2026, paying $1.255 billion in cash, subject to post-closing adjustments. The company says the deal adds about 16,500 net acres in Eddy and Lea Counties, New Mexico, and over 156 net drilling locations, and expects it to support free cash flow and debt repayment.
Closed October 1, 2026, for $1.255 billion in cash, subject to post-closing adjustments
Adds about 16,500 net, mostly undeveloped acres in Eddy and Lea Counties, New Mexico
Adds over 156 net locations; Matador expects to begin drilling up to 25 wells by year-end 2027
Expects to pay down its PNC Bank-led credit facility by $350-400 million in Q4 2026, depending on commodity prices
PTC signed a merger agreement under which Schneider Electric will acquire the company for $205 per share in cash, valuing PTC's equity at approximately $22.6 billion. The price is a 42.3% premium to PTC's last closing price, and PTC shareholders must approve the deal; closing is anticipated by Q3 2027. Shareholders would receive cash and the stock would be delisted from Nasdaq if the merger closes.
Merger consideration: $205 per share in cash; implied enterprise value of $23.7 billion
Premium of 42.3% to last closing price and 46.1% to the previous 30-trading-day VWAP
Company must pay Schneider Electric a $700 million termination fee in specified circumstances
Closing anticipated by Q3 2027, subject to majority shareholder approval and regulatory clearances including HSR and CFIUS
ChronoScale Holdings completed the sale of its Ekso Bionics subsidiary on September 30, 2026, and said it will focus on its AI infrastructure business. On October 1, 2026, it also announced an expanded agreement with an existing AI infrastructure customer and a new customer agreement, which together with existing contracts provide for $1 billion in annualized revenue run rate by calendar Q3 2027. The filing does not disclose the sale price or the company's profit results, and the revenue run-rate is a non-GAAP measure subject to deployment and financing risks.
Sale of Ekso Bionics, Inc., a wholly owned subsidiary, completed September 30, 2026; the filing does not state the sale price
Expanded AI infrastructure customer agreement and new customer agreement, announced October 1, 2026, with combined contracts targeting $1 billion annualized revenue run rate by calendar Q3 2027
Chief Operating Officer of Ekso, Jason C. Jones, terminated effective September 30, 2026, with severance of $243,750 plus up to nine months of COBRA premiums
Series B Convertible Preferred Stock designation withdrawn September 29, 2026; no preferred shares were outstanding
On October 1, 2026, CareTrust completed the purchase of 24 completed UK care homes from LNT Care Developments for £576 million (about $764 million), excluding transaction costs. The company also expects to acquire 21 more homes under development for £504 million (about $669 million) on a rolling basis through December 31, 2027, and raised its full-year 2026 guidance, which shareholders may view as a sign of improved earnings expectations.
24 completed care homes acquired October 1, 2026 for £576 million (about $764 million), excluding transaction costs
21 in-development homes to be acquired for £504 million (about $669 million) as they are completed and approved, through December 31, 2027
Full-year 2026 guidance raised: net income attributable to CareTrust of $1.54 to $1.57 per share and Normalized FFO of $2.06 to $2.09 per share
Initial closing funded by proceeds from settling outstanding forward equity agreements and a draw on the revolving credit facility
onsemi, Synaptics and Merger Sub signed an Amended and Restated Merger Agreement on October 1, 2026, after Synaptics received an unsolicited proposal from a third party. The revised deal is all-cash at $123 per share, with an aggregate value of about $5.7 billion versus about $7 billion under the prior agreement. onsemi says the transaction is now expected to be immediately accretive to non-GAAP earnings per share upon closing.
Merger consideration revised to $123 per share in cash; aggregate value about $5.7 billion, down from about $7 billion under the June 25, 2026 agreement.
Morgan Stanley Senior Funding, Inc. committed up to $2.45 billion of senior secured term loan under a commitment letter dated October 1, 2026.
onsemi expects the deal to be immediately accretive to non-GAAP EPS; the transaction is expected to close by mid-2027, subject to Synaptics shareholder approval and regulatory approvals.
The Federal Trade Commission has approved the transaction; regulators in other jurisdictions are still reviewing it.
Standard BioTools ended its agreement to sell its mass cytometry business to Multiplex Bio and agreed to sell it to Element Biosystems, a subsidiary of GMT Venture, for $5.5 million in cash. The company agreed to pay Multiplex Bio a $1.5 million termination fee, of which GMT Venture will pay $1.0 million, and says the Element deal increases its net cash position by about $15 million compared with the Multiplex Bio transaction, which the Treeline merger exchange ratio takes into account. Completion still depends on stockholder approval and the pending Treeline merger.
Multiplex Bio purchase agreement terminated on September 30, 2026; the company agreed to pay a $1.5 million termination fee, with GMT Venture paying $1.0 million of it on the company's behalf.
Element purchase price is $5.5 million in cash, on a cash-free and debt-free basis, with no financing condition and a GMT Venture equity commitment letter.
Closing requires stockholder approval and consummation of the Treeline merger; the company expects the Element deal to close by the end of 2026.
If the deal terminates in specified circumstances, the company owes Element a $1.0 million termination fee; expense reimbursements of up to $125,000 each apply if closing misses December 31, 2026 or March 31, 2027.
SoundThinking agreed on September 28, 2026 to be acquired by Transom Capital Group through a tender offer for $8.00 per share in cash plus one non-transferable contingent value right worth up to $3.00 per share. The up-front price is a 46% premium to the September 28, 2026 closing price, and holders of about 33% of the outstanding shares have already agreed to tender, so the deal would give shareholders a cash exit if completed.
Up-front cash of $8.00 per share, plus a CVR paying up to $3.00 per share tied to 2027 revenue milestones for ShotSpotter and SafePointe
Implied enterprise value of about $114 million on up-front consideration, or about $159 million with the maximum CVR payment
Veradace Partners (about 16%) and Gary M. Lauder and affiliates (about 17%) agreed to tender their shares; the offer requires more than 50% of outstanding shares to be tendered
Closing is expected in the fourth quarter of 2026; the deal has no financing condition, and shares will stop trading on Nasdaq once completed
The Marygold Companies agreed on September 25, 2026 to be acquired by funds managed by Madison Dearborn Partners, with stockholders to receive $2.00 per share in cash, a premium of approximately 100% over the September 24, 2026 closing price. Stockholders holding about 75% of the voting power have already approved the merger by written consent, and the company's common stock will be delisted from NYSE American once the deal closes, which is expected in the first half of 2027 or earlier.
Stockholders will receive $2.00 per share in cash, a premium of approximately 100% over the September 24, 2026 closing price.
Written stockholder consent from holders of about 75% of voting power was delivered on September 25, 2026, satisfying the stockholder approval condition.
Common stock will stop trading on NYSE American after closing; the company will become privately held.
A termination fee of approximately $2.6 million may be payable by the company in certain circumstances; the Termination Date is June 7, 2027.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Frequently asked questions
Which filings get a brief?
Form 8-K filings by companies listed on a US stock exchange (NYSE, Nasdaq, Cboe; not over-the-counter stocks) that report a material event: results (Item 2.02), deals (1.01, 2.01), executive changes (5.02), restructuring (2.05), impairments (2.06), delisting notices (3.01), restatements (4.02), cybersecurity incidents (1.05), bankruptcy (1.03) and Regulation FD or other events (7.01, 8.01). Routine filings such as vote results or exhibits only are skipped.
How is the impact score set?
The AI rates each filing from 1 (routine) to 5 (major, such as a merger, bankruptcy or restatement) based only on what the filing says. It is a reading aid for sorting the day's filings, not a prediction of how the stock will move.
How quickly do briefs appear?
On weekdays the SEC filing feed is checked every 5 minutes from 6 am to 5:45 pm Eastern, when nearly all 8-Ks come in, and every hour after that until 10 pm. Briefs of the 1,000 largest companies follow within minutes; the others usually within the hour, or later the same day when many filings arrive at once.
Which companies are covered?
Every company with shares listed on the NYSE, Nasdaq or Cboe that files 8-Ks, about 4,500 of them. Foreign companies that report on Form 6-K instead are not included. The S&P 1500 only filter above narrows the list to the large, mid and small caps of the S&P Composite 1500.
Are older briefs kept?
Yes. This page shows the last 45 days, but every brief ever published stays online: each has its own page, and each company has an 8-K page listing all of its briefs, newest first, linked from its stock page and from the A-Z list of companies.